Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$50.07 - $76.78 $1.2 Million - $1.84 Million
-23,900 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$58.92 - $97.33 $128,504 - $212,276
-2,181 Reduced 8.36%
23,900 $1.64 Million
Q4 2020

Feb 02, 2021

SELL
$43.6 - $73.05 $46,652 - $78,163
-1,070 Reduced 3.94%
26,081 $1.75 Million
Q3 2020

Nov 05, 2020

BUY
$38.47 - $52.03 $173,615 - $234,811
4,513 Added 19.94%
27,151 $1.4 Million
Q2 2020

Aug 12, 2020

BUY
$27.28 - $43.01 $617,564 - $973,660
22,638 New
22,638 $853,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $559M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.